Sergentanis TN - Search Results

1

GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP. Sergentanis TN, et al. Breast Cancer Res Treat. 2010 May;121(1):195-202. doi: 10.1007/s10549-009-0520-0. Epub 2009 Sep 17. Breast Cancer Res Treat. 2010. PMID: 19760040

2

Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study.

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Fotou M, Panopoulou E, Pararas N, Fotiadis C, Bramis J. Zografos GC, et al. Among authors: sergentanis tn. Breast Cancer Res Treat. 2008 May;109(2):397-402. doi: 10.1007/s10549-007-9662-0. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653855 Clinical Trial.

3

Early breast cancer diagnosis in Europe, 2007: disastrous exceptions exist.

Zografos GC, Zagouri F, Sergentanis TN, Domeyer PJ, Christopoulos P, Bramis J. Zografos GC, et al. Among authors: sergentanis tn. Breast J. 2009 Jan-Feb;15(1):101. doi: 10.1111/j.1524-4741.2008.00677.x. Breast J. 2009. PMID: 19141136 No abstract available.

4

Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.

Economopoulos KP, Sergentanis TN. Economopoulos KP, et al. Among authors: sergentanis tn. Breast Cancer Res Treat. 2010 Feb;120(1):211-6. doi: 10.1007/s10549-009-0467-1. Epub 2009 Jul 10. Breast Cancer Res Treat. 2010. PMID: 19590949

5

Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP. Sergentanis TN, et al. Breast Cancer Res Treat. 2010 Feb;120(1):229-34. doi: 10.1007/s10549-009-0471-5. Epub 2009 Jul 24. Breast Cancer Res Treat. 2010. PMID: 19629679

6

Need for clarification of data in the recent meta-analysis about p53 polymorphism and gastric cancer risk.

Economopoulos KP, Sergentanis TN. Economopoulos KP, et al. Among authors: sergentanis tn. Int J Cancer. 2010 May 15;126(10):2509. doi: 10.1002/ijc.24876. Int J Cancer. 2010. PMID: 19739120 No abstract available.

7

Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk.

Sergentanis TN, Economopoulos KP. Sergentanis TN, et al. Breast Cancer Res Treat. 2010 Feb;120(1):261-2. doi: 10.1007/s10549-009-0515-x. Epub 2009 Sep 17. Breast Cancer Res Treat. 2010. PMID: 19760041 No abstract available.

8

XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis.

Economopoulos KP, Sergentanis TN. Economopoulos KP, et al. Among authors: sergentanis tn. Breast Cancer Res Treat. 2010 Jun;121(2):439-43. doi: 10.1007/s10549-009-0562-3. Epub 2009 Sep 30. Breast Cancer Res Treat. 2010. PMID: 19789975

9

Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP. Sergentanis TN, et al. Breast Cancer Res Treat. 2010 Jul;122(2):459-69. doi: 10.1007/s10549-009-0694-5. Epub 2009 Dec 25. Breast Cancer Res Treat. 2010. PMID: 20035380 Review.

10

Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.

Economopoulos KP, Sergentanis TN. Economopoulos KP, et al. Among authors: sergentanis tn. Breast Cancer Res Treat. 2010 Jul;122(2):545-51. doi: 10.1007/s10549-009-0728-z. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054638 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters